List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 72 studies with search of: Open Studies | "Conjunctivitis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
Conditions: Ocular Itching;   Ocular Allergy;   Seasonal Allergic Conjunctivitis;   Perennial Allergic Conjunctivitis;   Conjunctivitis, Allergic
Interventions: Drug: PRO-118 Ophthalmic Solution 0.015%;   Drug: PRO-118 Ophthalmic Solution 0.015 %;   Drug: PRO-118 Ophthalmic Solution 0.020 %;   Drug: Placebo Ophthalmic Solution
2 Recruiting Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Condition: Adenoviral Conjunctivitis
Interventions: Drug: NVC-422 Ophthalmic Solution, 0.33%;   Drug: Vehicle Ophthalmic Solution
3 Not yet recruiting FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Condition: Acute Adenoviral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 (Component #1);   Drug: FST-100 Vehicle
4 Recruiting The Effect of BEPREVE 1.5% as Treatment of Itching Associated With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: Bepreve® 1.5% solution
5 Recruiting A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
6 Not yet recruiting Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: bepotastine besilate, 1.5%;   Drug: Loteprednol etabonate
7 Not yet recruiting Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
8 Not yet recruiting Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
9 Not yet recruiting Efficacy/Safety of Human Plasminogen EyeDrop in Ligneous Conjunctivitis Patients
Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
10 Recruiting A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
Conditions: Conjunctivitis, Seasonal Allergic;   Conjunctivitis, Giant Papillary;   Inflammation
Intervention: Drug: Loteprednol Etabonate
11 Not yet recruiting Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
12 Not yet recruiting FST-100 in the Treatment of Acute Viral Conjunctivitis
Condition: Acute Viral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 Vehicle
13 Recruiting A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: DE-114 ophthalmic solution
14 Recruiting Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Besivance;   Drug: Gatifloxacin
15 Recruiting Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
16 Recruiting Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
Condition: Allergic Conjunctivitis
Interventions: Drug: AL-4943A Ophthalmic Solution;   Drug: AL-4943A Ophthalmic Solution Vehicle;   Drug: Pataday
17 Recruiting An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin Ophthalmic Solution, 0.5%;   Drug: Ofloxacin Ophthalmic Solution, 0.3%
18 Recruiting An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: AKF-1
19 Recruiting A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
20 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services